KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Payables (2016 - 2025)

Bausch Health Companies' Payables history spans 17 years, with the latest figure at $600.0 million for Q4 2025.

  • For Q4 2025, Payables rose 1.87% year-over-year to $600.0 million; the TTM value through Dec 2025 reached $600.0 million, up 1.87%, while the annual FY2025 figure was $600.0 million, 1.87% up from the prior year.
  • Payables for Q4 2025 was $600.0 million at Bausch Health Companies, down from $616.0 million in the prior quarter.
  • Across five years, Payables topped out at $719.0 million in Q4 2023 and bottomed at $407.0 million in Q4 2021.
  • The 5-year median for Payables is $579.0 million (2024), against an average of $572.1 million.
  • The largest annual shift saw Payables skyrocketed 38.0% in 2023 before it dropped 18.08% in 2024.
  • A 5-year view of Payables shows it stood at $407.0 million in 2021, then rose by 28.01% to $521.0 million in 2022, then soared by 38.0% to $719.0 million in 2023, then fell by 18.08% to $589.0 million in 2024, then rose by 1.87% to $600.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Payables are $600.0 million (Q4 2025), $616.0 million (Q3 2025), and $627.0 million (Q2 2025).